Financhill
Sell
31

JAGX Quote, Financials, Valuation and Earnings

Last price:
$1.01
Seasonality move :
-21.37%
Day range:
$1.00 - $1.08
52-week range:
$0.84 - $21.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.41x
P/B ratio:
0.94x
Volume:
415.9K
Avg. volume:
572.7K
1-year change:
-85.51%
Market cap:
$12.9M
Revenue:
$9.8M
EPS (TTM):
-$16.18

Earnings Data

Next earnings date for JAGX
Apr 01
2025
Most recent earnings per share
-$1.05
Beat by $1.32
(Nov 13/2024)
Consensus Estimate
-$2.37
(Nov 13/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JAGX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/01/2025 Q1 $3.3M -- -- -$0.72 --
12/31/2024 Q4 $3.1M -- -- -$0.74 --
11/13/2024 Q3 $3.9M $3.1M -$1.05 -$2.37 $1.32
08/13/2024 Q2 $3.4M $2.7M -$4.04 -$1.20 -$2.84
05/14/2024 Q1 $3M $2.4M -$3.60 -$1.80 -$1.80
03/27/2024 Q4 -- $2.3M -$7.49 -- --
11/14/2023 Q3 -- -- -$22.50 -$73.80 $51.30
06/30/2023 Q2 -- -- -$41.35 -$91.80 $50.45
05/10/2023 Q1 -- -- -$143.40 -- --
03/14/2023 Q4 -- -- -$208.45 -$315.00 $106.55
11/15/2022 Q3 -- -- -$529.80 -- --
08/12/2022 Q2 -- -- -$526.20 -- --
05/10/2022 Q1 -- -- -$1,386.00 -- --
03/31/2022 Q4 -- -- -$1,332.06 -- --
11/15/2021 Q3 -- -- -$1,215.00 -- --
08/13/2021 Q2 -- -- -$1,395.00 -- --
05/17/2021 Q1 -- -- -$1,260.00 -- --
03/31/2021 Q4 -- -- -$1,345.49 -- --
11/16/2020 Q3 -- -- -$2,790.00 -- --
06/30/2020 Q2 -- -- -$5,940.01 -- --
03/31/2020 Q1 -- -- -$7,560.01 -- --
12/31/2019 Q4 -- -- -$7,528.64 -- --
11/15/2019 Q3 -- -- -$16,595.17 -- --
08/14/2019 Q2 -- -- -$118,588.65 -- --
03/31/2019 Q1 -- -- -$116,957.75 -- --
12/31/2018 Q4 -- -- -$342,908.38 -- --
09/30/2018 Q3 -- -- -$341,019.56 -- --
06/30/2018 Q2 -- -- -$508,951.94 -- --
03/31/2018 Q1 -- -- -$393,625.71 -- --
12/31/2017 Q4 -- -- -$1,554,419.85 -- --
09/30/2017 Q3 -- -- $475,984.40 -- --
06/30/2017 Q2 -- -- -$1,805,642.00 -- --
03/31/2017 Q1 -- -- -$4,715,358.00 -- --
12/31/2016 Q4 -- -- -$3,676,611.00 -- --
09/30/2016 Q3 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -$4,124,469.00 -- --

Jaguar Health Earnings Questions

  • How Much did Jaguar Health Generate in Revenue Last Quarter?

    Jaguar Health reported $3.1M worth of top line sales in its most recent quarter.

  • Did Jaguar Health Beat Earnings Last Quarter?

    Jaguar Health announced earnings per share of -$1.05 which represents a beat of analyst forecast a -$2.37 per share.

  • Is Jaguar Health Profitable?

    Jaguar Health reported $2.6M that represents $0.27 per share over the last quarter.

  • What is the Analyst Consensus for Jaguar Health EPS Next Year?

    Jaguar Health's earnings are forecast to decrease from -$107.40 per share to -$2.06 per share next year representing a decrease of -94.97%.

  • When is Jaguar Health's Earnings Date?

    Jaguar Health's next earnings date is April 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 11

IonQ [IONQ] is up 7.07% over the past day.

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
2
CRNX alert for Jan 11

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock